Yazar "Yalçın, Ebru" için listeleme
-
CFTR mutations unidentified in CFTR2 database and their phenotypic characteristics: Data from cystic fibrosis registry of Turkey
Cinel, Güzin; Doğru, Deniz; Çakır, Erkan; Eyüboğlu, Tuğba Şişmanlar; Çobanoğlu, Nazan; Pekcan, Sevgi; Yalçın, Ebru; Can, Demet (European Respiratory Soc Journals Ltd, 2020)Abstract Background: Cystic Fibrosis Registry of Turkey shows various CFTR mutations due to the geographical location and historical background of our country, and also high prevalence of consanguineous marriages. Method:All ... -
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis
Eyüboğlu, Tuğba Şişmanlar; Doğru, Deniz; Çakır, Erkan; Çobanoğlu, Nazan; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Can, Demet (Wiley, 2020)Background Pseudo-Bartter syndrome (PBS) is a rare complication of cystic fibrosis (CF) and there are limited data in the literature about it. We aimed to compare clinical features and accompanying findings of patients ... -
Cystic fibrosis in Turkey: First data from the national registry
Doğru, Deniz; Çakır, Erkan; Şişmanlar, Tuğba; Çobanoğlu, Nazan; Pekçan, Sevgi; Çinel, Güzin; Yalçın, Ebru; Can, Demet (Wiley, 2019)Background Cystic fibrosis (CF) care has been implemented in Turkey for a long time; however, there had been no patient registry. For this purpose, the Turkish National CF Registry was established. We present the first ... -
Cystic fibrosis patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Çobanoğlu, Fatma Nazan; Ersöz, Deniz Doğru; Çakır, Erkan; Eyuboğlu, Tuğba; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Can, Demet (European Respiratory Soc Journals Ltd, 2019)Better understanding of CFTR biology has led to the development of modulator drugs. Lumacaftor/Ivacaftor (L/T) is approved for people ages ≥2 who have two copies of the F508del mutation. Tezacaftor/Ivacaftor (T/I) is ... -
Evaluation of respiratory function at 6 years of age in patients with cystic fibrosis with frequent pulmonary exacerbations in the first 2 years of life
Tabakçı, Satı Özkan; Cinel, Güzin; Uytun, Salih; Polat, Sanem Eryılmaz; Yalçın, Ebru; Kiper, Nural; Erdal, Meltem Akgül; Can, Demet (European Respiratory Soc Journals Ltd, 2023)Özet bilgisi yok. -
Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study
Emiralioğlu, Nagehan; Çakır, Banu; Sertçelik, Ahmet; Yalçın, Ebru; Kiper, Nural; Şen, Velat; Altıntaş, Derya Ufuk; Can, Demet (John Wiley and Sons, 2024)Background: The decline in pulmonary function is a predictor of disease progression in patients with cystic fibrosis (CF). This study aimed to determine the decline rate of percent predicted forced expiratory volume in 1 ... -
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Çobanoğlu, Fatma Nazan; Özçelik, Uğur; Çakır, Erkan; Eyüboğlu, Tuğba Şişmanlar; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Can, Demet (Wiley, 2020)Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacafto ... -
Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
Uytun, Salih; Cinel, Güzin; Polat, Sanem Eryılmaz; Tabakçı, Satı Özkan; Kiper, Nural; Yalçın, Ebru; Tural, Dilber Ademhan; Can, Demet (Wiley, 2023)BackgroundCystic fibrosis (CF) is an autosomal recessive disorder caused by CF transmembrane conductance regulator (CFTR) genetic variants. CFTR modulators improve pulmonary function and reduce respiratory infections in ... -
The success of the cystic fibrosis registry of Turkey for improvement of patient care
Asfuroğlu, Pelin; Eyüboğlu, Tuğba Sişmanlar; Aslan, Ayşe Tana; Gürsoy, Tuğba Ramasli; Emiralioğlu, Nagehan; Yalçın, Ebru; Kiper, Nural; Can, Demet (Wiley, 2022)Background Cystic fibrosis (CF) registries play an essential role in improving disease outcomes of people with CF. This study aimed to evaluate the association of newly established CF registry system in Turkey on follow-up, ...
